Results

Selecta Biosciences Inc.

11/24/2021 | Press release | Distributed by Public on 11/24/2021 15:23

Selecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia - Form 8-K